Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1 Papillomavirus Infections 1 Papilloma 1 Leiomyoma 1 Inflammation 1 Frailty 1

Interventions

estradiol, norethindrone drug combination 9 asoprisnil 9 Uterine Myomectomy 9 telapristone acetate 8 Uterine Artery Embolization 8 ulipristal acetate 7 relugolix 7 elagolix 7 Estradiol 7 vilaprisan 5 Norethindrone Acetate 5 Mifepristone 5 ulipristal 4 linzagolix 4 Leuprolide 4 Tranexamic Acid 3 Sodium Chloride 3 Hysterectomy 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 cetrorelix 2 Saline Solution 2 Radiofrequency Ablation 2 Progestins 2 Lidocaine 2 Letrozole 2 Goserelin 2 Endometrial Ablation Techniques 2 Anesthesia, General 2 pirfenidone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Leiomyoma × epigallocatechin gallate × Clear all

NCT04177693 2023-06-05

Pharmacokinetics and Hepatic Safety of EGCG

Yale University

Phase 1 Completed

39 enrolled 18 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡